MĀNUKA PERFORMANCE LIMITED
An Advanced Bioactive Nutrition Company · New Zealand
01
The Problem
WHAT PROBLEM
ARE WE
SOLVING?
MILLIONS OF PEOPLE.
NO SOLUTION.
Three large, urgent, and underserved nutritional gaps exist right now — and no single company is addressing all three with validated, science-backed products.
31M
Americans currently on GLP-1 weight-loss drugs — eating far less, with documented protein, fibre and micronutrient deficits. No dedicated nutrition system exists for them.
550K
US marathon finishers annually seeking clean, natural, science-verified energy and recovery — a premium segment poorly served by mass-market sports nutrition.
$4.5B
US gut health supplement market — yet consumers and clinicians alike struggle to find products with independently verified bioactive profiles they can actually trust.
02
The Product
HOW UNIQUE
IS WHAT
WE HAVE?
NOBODY ELSE
HAS THIS.
NOBODY CAN.
Our products are built on PolySure™ — a proprietary 7-polyphenol bioactive system derived from New Zealand's native honey varieties: Mānuka, Rewarewa, Kāmahi, Tāwari, Pōhutukawa, and Rātā. Geographically irreplaceable. Independently verified to ISO-17025. Exclusive sourcing. Physician-led commercial channels. The combination of NZ indigenous provenance, clinical science, and a physician co-president in the US market is not replicable. Not in 12 months. Not in five years.
7
Polyphenols tracked per batch — ISO-17025 verified. Certificate of Analysis on every production run. No competitor does this.
6+
Native NZ honey varieties — geographically protected, genetically unique, exclusively sourced. The raw material cannot be manufactured elsewhere.
1
Physician co-president in the US with active telehealth prescriber networks — the clinical credibility channel competitors cannot buy their way into.
03
The Upside
HOW BIG
CAN THIS
GET?
THREE MARKETS.
$28B+ COMBINED
US OPPORTUNITY.
We are entering three US markets simultaneously — each large, each growing, each with a defensible first-mover position available. Capital raised now funds the channel build that locks in that position before the window closes.
$18B
US sports nutrition TAM · SAM $3.2B premium endurance · SOM $8–15M (5yr)
$4.5B
US gut health supplement TAM · SAM $1.2B bioactive-led · SOM $4–8M (5yr)
$6B
US GLP-1 companion nutrition TAM (2027 est.) · SAM $2.4B · SOM $20–40M (5yr)
Y2
EBITDA positive · 60% gross margin · No bridge round required · Single raise finances to profitability
04
Product / Market Fit
ONE RAW
MATERIAL.
INFINITE
VALUE.
THE NZ HONEY
CONUNDRUM.
Wattie's didn't sell tomatoes. They sold sauce, soup, paste, ketchup — and built a company worth hundreds of millions. The tomato was just the beginning. This is our version of that story. The entire honey industry sells honey. We start where they stop. New Zealand's native honey is our raw material — geographically irreplaceable, scientifically extraordinary, and the foundation from which everything else is engineered. We do not compete in the commodity space. We never have. We take the whole tomato and turn it into something the industry has never seen.
🍯
The Origin
NZ NATIVE HONEY
Mānuka · Rewarewa · Kāmahi · Tāwari · Pōhutukawa · Rātā · Blend Systems
The world's most bioactively complex honey matrix. Seven polyphenols tracked per batch to ISO-17025. Geographically protected. Exclusively sourced. This is where the industry stops. This is where we start.
Where we start
Where we take it
ENGINEERED
Bioactive Formulations
PolySure™ Certified Powder Systems
Spray-dried bioactive honey powders with verified polyphenol profiles. Sold to nutraceutical brands, food manufacturers, and supplement contract producers globally. Not a commodity ingredient — a certified bioactive system with a CoA on every batch.
B2B Premium
Food Service & Brand Formulations
Engineered honey-based formulation systems for food service operators, functional beverage brands, and RTD manufacturers. Delivered as ready-to-use bioactive bases — not raw ingredients.
B2B Premium
VALIDATED
Consumer Products
LiquidFuel™ — Sports Energy
Dual-carb bioactive gel for endurance athletes. Live in South Korea + Amazon USA. Clean label, natural format, scientifically validated. A step-change from synthetic gels dominating the market.
$29–34 USD / 30-pack
GI-PRO™ — Gut Health
Mānuka + BC30™ (2 billion CFU, FDA GRAS) + prebiotic fibre. Once-daily sachet. Active RCT underway. China CBEC launch SKU. The first gut health product with an independently verified honey bioactive foundation.
$39–49 USD / 30-pack
GLP-1 Nutrition Stack
Four-SKU physician-backed daily nutrition system for GLP-1 therapy patients. Closes the documented protein, fibre, and micronutrient gap. Telehealth B2B + D2C. No equivalent product exists.
$79–126 USD / 30-day
PROPRIETARY
Platform & IP
PolySure™ IP Licensing
The 7-polyphenol certification framework and CoA methodology licensed to third-party manufacturers and ingredient brands globally. Recurring royalty. Compounds in value with every certification issued.
Royalty stream
EquiEnhance™ — Elite Equine
PolySure™ bioactive system adapted for performance horses. HK Jockey Club, UAE and Middle East bloodstock. High spend-per-animal. No credible science-backed competitor in this niche.
Premium USD
Bioactive Intelligence Platform
AI-enabled system mapping polyphenol profiles, therapeutic applications, and clinical outcomes — in development. Licensable to pharma, food tech, and research institutions as the dataset matures.
SaaS / licensing
Every tier above generates revenue independently. Every tier reinforces the others. The IP compounds. The certifications multiply in value. The clinical data opens new markets. This is not a product company with one exit. It is a platform with many.
05
The Structure
WHY NEW
ZEALAND.
WHY NOW.
NZ$5M BUYS YOU
RESIDENCY, RETURNS,
AND A REAL MOAT.
Mānuka Performance is structured to qualify under New Zealand's Active Investor Plus (AIP) Growth Category — one of the world's most investor-friendly residency pathways. NZ$5M direct investment. Just 21 days in-country over three years. No English requirement. Full family residency. No cap on annual visas. The investment works commercially on its own merits — the residency is the bonus.
NZD $5M
Minimum AIP Growth Category · Direct investment into MPL
21 days
In-country required over 3 years · Full family residency included
#1
Most prosperous country outside Europe · Legatum Index 2024
#2
Government integrity & freedom of trade · Index of Economic Freedom 2024
#3
Most peaceful country globally · Global Peace Index 2025
0%
Capital gains tax in New Zealand · No inheritance tax · No gift duty
New Zealand is not the market — it is the origin. The IP, the science, the provenance, and the manufacturing are here. The markets are global. NZ's trusted food safety reputation, clean-green brand equity, and 200+ years of premium export heritage open doors that no other country of origin can match. The investment is into a globally trading business. The address just happens to be one of the best in the world.
Full materials available · NDA required to proceed
This document contains no financial projections or commercially sensitive data. Detailed investor brief, financial model, and clinical data available to qualified investors under executed NDA.